...
首页> 外文期刊>Cell death & disease. >Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways
【24h】

Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways

机译:miR-146b-3p对HPGD的下调通过激活STAT3和AKT途径促进宫颈癌细胞的增殖,迁移和锚定非依赖性生长

获取原文
           

摘要

While the application of early screening and HPV vaccines has reduced the incidence and mortality rates of cervical cancer, it remains the third most common carcinoma and fourth leading cause of cancer-associated death among women worldwide. The precise mechanisms underlying progression of cervical cancer are not fully understood at present. Here, we detected significant down-regulation of 15-hydroxyprostaglandin dehydrogenase (HPGD) in cervical cancer tissues. Overexpression of HPGD inhibited cervical cancer cell proliferation, migration and anchorage-independent growth to a significant extent. To clarify the mechanisms underlying HPGD down-regulation in cervical cancer, miRNA microarray, bioinformatics and luciferase reporter analyses were performed. HPGD was identified as a direct target of miR-146b-3p displaying up-regulation in cervical cancer tissues. Similar to the effects of HPGD overexpression, down-regulation of miR-146b-3p strongly suppressed proliferation, migration and anchorage-independent growth of cervical cancer cells. Furthermore, HPGD negatively regulated activities of STAT3 and AKT that promote cervical cancer cell proliferation. Notably, HPV oncogenes E6 and E7 were determined as potential contributory factors to these alterations. Our results collectively suggest that the HPGD/miR-146b-3p axis plays a significant role in cervical cancer and may serve as a potentially effective therapeutic target.
机译:尽管早期筛查和HPV疫苗的使用降低了子宫颈癌的发病率和死亡率,但它仍然是全世界女性中第三大最常见的癌症,也是癌症相关死亡的第四大主要原因。目前尚不完全了解子宫颈癌发展的确切机制。在这里,我们检测到宫颈癌组织中15-羟前列腺素脱氢酶(HPGD)明显下调。 HPGD的过度表达在很大程度上抑制了宫颈癌细胞的增殖,迁移和锚定非依赖性生长。为了阐明HPGD在宫颈癌中下调的机制,进行了miRNA芯片,生物信息学和荧光素酶报告基因分析。 HPGD被确定为miR-146b-3p的直接靶标,在宫颈癌组织中表现出上调。与HPGD过表达的作用类似,miR-146b-3p的下调强烈抑制宫颈癌细胞的增殖,迁移和锚定非依赖性生长。此外,HPGD对促进宫颈癌细胞增殖的STAT3和AKT的活性负调节。值得注意的是,HPV致癌基因E6和E7被确定为导致这些改变的潜在因素。我们的结果共同表明,HPGD / miR-146b-3p轴在子宫颈癌中起重要作用,并且可能充当潜在的有效治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号